Cramer's lightning round: People are too negative on this biotech play
March 30, 2017 at 18:50 PM EDT
Jim Cramer rattles off his take on caller favorite stocks, among them this embattled biotech name.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.